<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Moderna Releases 94.5% Efficacious Clinical Trial Results
Image Overlay - Moderna Releases 94.5% Efficacious Clinical Trial Results

Moderna Releases 94.5% Efficacious Clinical Trial Results

Moderna Releases 94.5% Efficacious Clinical Trial Results

Moderna has released clinical trial results that indicate its vaccine is 94.5% effective in preventing the coronavirus. A total of 30,000 volunteers were recruited for the study – half received two doses of the vaccine 28 days apart while the other 50% received a placebo. Of those, 95 participants contracted COVID-19, though only 5 were from the group that received the vaccine. Yourway has an advanced direct-to-patient program to help encourage clinical trial retention and patient access, especially during various country-wide lockdowns.

Back to Index
Media

Upcoming Events

Clinical Trial Supply East Coast 2022

October 19-20, 2022
King of Prussia, PA, USA

Media

Articles

Helping Sponsors Navigate Complex Ancillary Supply Sourcing Challenges with Integrated Services

Open chat
Come chat with us!
Hello! How can I help you?